Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316788 | SCV000850519 | uncertain significance | Inborn genetic diseases | 2017-03-15 | criteria provided, single submitter | clinical testing | The p.P294A variant (also known as c.880C>G), located in coding exon 6 of the ALG13 gene, results from a C to G substitution at nucleotide position 880. The proline at codon 294 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001444513 | SCV001647518 | likely benign | Developmental and epileptic encephalopathy, 36 | 2024-04-19 | criteria provided, single submitter | clinical testing |